Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.
5-HT2 RECEPTORS FACILITATE JC POLYOMAVIRUS ENTRY.
Myeloid cells as target of fingolimod action in multiple sclerosis.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression.
Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosis.
M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity.
Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Role of STIM-dependent Ca(2+) Influx in Regulatory B Cells.
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab.
T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1.
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: No.
Colour vision impairment is associated with disease severity in multiple sclerosis.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases.
The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.
Next-generation sequencing in understanding complex neurological disease.
Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases.
N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions.
[Multiple sclerosis and peripheral neuropathy].
Health related quality of life in patients recently diagnosed with multiple sclerosis.
Pages
« first
‹ previous
…
343
344
345
346
347
348
349
350
351
…
next ›
last »